XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
HK Stock MarketDetailed Quotes
03347 TIGERMED
- 32.550
- +0.350+1.09%
Market Closed Dec 24 12:08 CST
28.15BMarket Cap26.44P/E (TTM)
32.700High32.000Low266.90KVolume32.000Open32.200Pre Close8.68MTurnover0.22%Turnover Ratio12.59P/E (Static)864.95MShares58.80052wk High1.21P/B4.01BFloat Cap21.47652wk Low0.62Dividend TTM123.12MShs Float197.719Historical High0.624Dividend LFY2.17%Amplitude21.476Historical Low32.503Avg Price100Lot Size1.92%Div YieldTTM1.92%Div Yield LFY
About TIGERMED Company
The company is an industry-leading integrated biomedical R&D service platform, providing innovative R&D solutions spanning the full cycle for the global pharmaceutical and medical device industry. Through a comprehensive service system and top quality standards, we help the biomedical industry improve R&D efficiency, reduce R&D risks, ensure high-quality delivery of research projects, accelerate the marketization process of pharmaceutical products, and fulfill our promises to the industry and patients. The company is a contract research organization (CRO) focusing on providing professional services throughout the clinical trial process for new drug research and development. It provides comprehensive and comprehensive clinical research solutions for global pharmaceutical and medical device innovators, ensures research quality, reduces R&D risks, shortens R&D cycles, saves R&D expenses, and promotes the product marketization process, so that patients can use newer and better pharmaceuticals and medical products as soon as possible. The services provided by the company mainly include clinical trial technical services and clinical trial-related services and laboratory services. Corporate honors: Eli Lilly Global Supplier Award, MSD Supplier Outstanding Service Award, Top 10 Listed Chinese Pharmaceutical Companies with the Most Investment Value, etc.
Company Profile
Symbol03347
Company NameTIGERMED
ISINCNE1000040M1
Listing DateAug 7, 2020
Issue Price100.00
Shares Offered107.07M share(s)
FoundedDec 15, 2004
Registered AddressChina
Chairmanxiaoping ye
Secretarymeiyi weng
Audit InstitutionLixin Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeRoom 2001-2010, 20th Floor, Building 8, No. 19, Jugong Road, Xixing Street, Binjiang District, Hangzhou, Zhejiang
Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees9348
MarketHong Kong motherboard
Phone0571-89986795
Fax0571-89986795
Emailir@tigermedgrp.com
Websitehttp://www.tigermedgrp.com
BusinessServices: Technology development, technical consulting, transfer of results for pharmaceutical-related industry products and health-related industrial products, management and statistical analysis of clinical trial data, translation, information technology and business process outsourcing services such as data processing by undertaking service outsourcing, non-certified labor vocational skills training for adults, uncultural education and training for adults, collection, collation, storage and publication of talent supply and demand information, career introduction, and talent information consultation. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)
Company Executives
- Name
- Position
- Salary
- xiaoping ye
- Chairman, Executive Director, Chairman of the Strategy Development Committee, Authorized Representative
- 2.92M
- xiaochun cao
- Executive Director, General Manager, Remuneration Committee Members
- 1.16M
- hao wu
- Co-President, Executive Director, Member of the Strategy Development Committee
- 2.61M
- zengyu wen
- Executive Vice President, Executive Director, Deputy General Manager, Chief Operating Officer, Nomination Committee Members
- 1.20M
- qiyu liao
- Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
- 220.00K
- huagang yuan
- Independent Non-Executive Director, Remuneration Committee Chairman, Member of the Strategy Development Committee, Audit Committee Members
- 122.00K
- yuwen liu
- Independent Non-Executive Director, Chairman of the Nomination Committee, Member of the Strategy Development Committee, Audit Committee Members
- --
- binghui zhang
- Chairman of the Supervisory Board, Non-employee Representative Supervisor
- 80.00K
- zhimin chen
- Shareholder Supervisors
- 80.00K
- wenqing lou
- Employee Representative Supervisor
- 140.00K
- chengcheng yang
- Head of Finance, the Person in Charge of Accounting
- --
- xiaori li
- Board Secretary
- --
- meiyi weng
- Authorized Representative, Company Secretary
- --
Trending HK Stocks
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.
